<SEC-DOCUMENT>0001140361-25-032643.txt : 20250826
<SEC-HEADER>0001140361-25-032643.hdr.sgml : 20250826
<ACCEPTANCE-DATETIME>20250826123054
ACCESSION NUMBER:		0001140361-25-032643
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250826
FILED AS OF DATE:		20250826
DATE AS OF CHANGE:		20250826

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IPERIONX Ltd
		CENTRAL INDEX KEY:			0001898601
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS METAL ORES [1090]
		ORGANIZATION NAME:           	01 Energy & Transportation
		EIN:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41338
		FILM NUMBER:		251254946

	BUSINESS ADDRESS:	
		STREET 1:		129 W TRADE STREET
		STREET 2:		SUITE 1405
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28202
		BUSINESS PHONE:		9802378900

	MAIL ADDRESS:	
		STREET 1:		129 W TRADE STREET
		STREET 2:		SUITE 1405
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Hyperion Metals Ltd
		DATE OF NAME CHANGE:	20211210
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ef20054495_6k.htm
<DESCRIPTION>6-K
<TEXT>
<html style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
  <head>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.7.1.5324
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff">
  <font style="font-size: 10pt;"> </font>
  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM 6-K</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER</div>
      <div style="text-align: center; font-weight: bold;">Pursuant to Rule 13a-16 or 15d-16 of the</div>
      <div style="text-align: center; font-weight: bold;">Securities Exchange Act of 1934</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">Date: August 26, 2025</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Commission File Number:</font><font style="font-size: 10pt;">&#160;<font style="font-weight: bold;">001-41338</font></font></div>
      <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt;"><font style="font-weight: bold;"> <br>
          </font></font></div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-size: 24pt; font-weight: bold;">IperionX Limited</div>
      <div style="text-align: center; font-weight: bold;">(Translation of registrant&#8217;s name into English)</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">129 W Trade Street, Suite 1405</div>
      <div style="text-align: center; font-weight: bold;">Charlotte, North Carolina</div>
      <div style="text-align: center; font-weight: bold;">(Address of principal executive offices)</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: left; text-indent: 36pt;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
      <div><br>
      </div>
      <div style="text-align: center; font-size: 14pt;"><font style="font-size: 10pt;">Form 20-F &#9746;&#160; &#160; Form 40-F &#9744;</font></div>
      <div><br>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">EXHIBIT INDEX</div>
      <div style="text-align: left;">The following exhibits are filed as part of this Form 6-K:</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z1b2159b7924f41548aea106a6b7382a8" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 9.82%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center;">Exhibit</div>
            </td>
            <td style="width: 4.87%; vertical-align: bottom;">&#160;</td>
            <td style="width: 85.31%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Description</div>
            </td>
          </tr>
          <tr>
            <td style="width: 9.82%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 4.87%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 85.31%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 9.82%; vertical-align: top;">
              <div><a href="ef20054495_ex99-1.htm">99.1</a></div>
            </td>
            <td style="width: 4.87%; vertical-align: top;">&#160;</td>
            <td style="width: 85.31%; vertical-align: top;">
              <div>Press Release</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
      <div style="text-align: center;"> <br>
      </div>
      <div style="text-align: left;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z5e3fefaf9211487a9e552e5a28689b0e" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div>IPERIONX LIMITED</div>
            </td>
            <td style="width: 32%; vertical-align: top;" rowspan="1" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div>(registrant)</div>
            </td>
            <td style="width: 32%; vertical-align: top;" rowspan="1" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 15%; vertical-align: bottom;"><br>
            </td>
            <td style="width: 32%; vertical-align: bottom;" colspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom; padding-bottom: 2px;">
              <div>Date: August 26, 2025</div>
            </td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">By:</td>
            <td style="width: 15%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>/s/ Marcela Castro</div>
            </td>
            <td style="width: 32%; vertical-align: bottom; padding-bottom: 2px;" colspan="1"><br>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">Name:</td>
            <td style="width: 45%; vertical-align: bottom;">
              <div>Marcela Castro</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 5%; vertical-align: top;">Title:</td>
            <td style="width: 45%; vertical-align: bottom;">
              <div>Chief Financial Officer</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: left;"><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20054495_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">
  <head>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.7.1.5324
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff">
  <font style="font-size: 10pt;"> </font>
  <div style="font-family: 'Times New Roman'; font-size: 10pt;">
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
      </div>
      <div>&#160;
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z33230bc5f87041c48e8188936d03022f">

            <tr>
              <td style="width: 50.00%;" rowspan="2" colspan="1"><img src="image00001.jpg"><br>
              </td>
              <td style="width: 50.00%;">
                <div style="text-align: right; color: rgb(0, 37, 84); font-size: 8pt;"><font style="font-weight: bold; font-size: 10pt;">PRESS RELEASE</font><font style="font-size: 10pt;"> | NASDAQ: IPX | ASX: IPX</font></div>
              </td>
            </tr>
            <tr>
              <td style="width: 50.00%;">
                <div style="text-align: right; color: rgb(0, 37, 84); font-style: italic;">August 26, 2025</div>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-style: normal; font-weight: bold;">IPERIONX RECEIVES $12.5M U.S. GOVERNMENT FUNDING TO ACCELERATE EXPANSION OF U.S. TITANIUM PRODUCTION</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: #171717;"><font style="font-weight: bold;">IperionX Limited (NASDAQ: IPX, ASX: IPX) (IperionX)</font> announces that the U.S. Department of Defense (DoD) has obligated US$12.5 million under IperionX&#8217;s
        previously announced US$47.1 million award to strengthen the U.S. Defense Industrial Base by accelerating the scale-up of a resilient, low-cost, and fully-integrated U.S. mineral-to-metal titanium supply chain.</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(23, 23, 23);">In response to the strategic need for increased production capacity of domestic primary titanium metal and manufactured titanium metal components, the project scope under the Industrial Base
        Analysis and Sustainment (IBAS) program has been revised to prioritize accelerated expansion of IperionX&#8217;s titanium metal and manufacturing production capacity at IperionX&#8217;s Virginia Titanium Manufacturing Campus.&#160; </div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(23, 23, 23);">The&#160; US$12.5 million will be applied to purchase orders for long-lead, major capital equipment required for the next stage of capacity scale-up to over 1,000 metric tons per year at the
        Virginia Titanium Manufacturing Campus. Major incremental capacity categories include titanium deoxygenation, sintering and powder metallurgy consolidation systems; near-net-shape component manufacturing and ancillary infrastructure upgrades.
        IperionX will provide a market update with additional details on the accelerated growth plans for the Virginia Titanium Manufacturing Campus.</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(23, 23, 23);">The US$12.5 million in funding follows on from the US$5 million previously obligated to advance the titanium, zircon and rare earth critical mineral-rich &#8216;Titan Critical Minerals Project&#8217; in
        Tennessee to shovel-ready status, with a definitive feasibility study underway and on-track for completion in the first half of 2026.</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(23, 23, 23);">Total funding obligations received under the DoD award now stand at US$17.5 million, with the remaining US$29.6 million expected to be obligated by the DoD over the contract term to support
        additional titanium production capacity at the Virginia Titanium Manufacturing Campus.</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(23, 23, 23); font-weight: bold;">Anastasios (Taso) Arima, IperionX CEO said: </div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(22, 22, 22); font-style: italic;">&#8220;This new U.S. Government obligation allows IperionX to move immediately to secure long-lead capital equipment and lock in manufacturing slots with key suppliers. It
        accelerates our imminent Virginia expansion beyond 1,000 tpa of high-performance titanium manufactured products, and advances a fully integrated, low-cost and traceable American titanium supply chain for defense and commercial customers. </div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(22, 22, 22); font-style: italic;">We are executing a multi-phase modular scale-up in titanium production and manufacturing capacity &#8212; and this commitment from the DoD is a strong endorsement of our
        technology, our team, and our mission to reshore a resilient titanium production supply chain in the United States.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(23, 23, 23); font-style: normal; font-weight: normal;">This announcement has been authorized for release by the CEO and Managing Director. </div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(23, 23, 23); font-style: normal; font-weight: normal;">For further information and enquiries please contact:</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(23, 23, 23); font-style: normal; font-weight: bold;">info@iperionx.com </div>
      <div style="text-align: justify; color: rgb(23, 23, 23); font-weight: bold;">+1 980 237 8900</div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z4804aa8f37384d66a4d9a180673ca2df">

            <tr>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; color: rgb(0, 37, 84); font-weight: bold;"><a name="z_Hlk126512181"></a>North Carolina</div>
              </td>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; color: rgb(0, 37, 84); font-weight: bold;">Tennessee</div>
              </td>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; color: rgb(0, 37, 84); font-weight: bold;">Virginia</div>
              </td>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; color: rgb(0, 37, 84); font-weight: bold;">Utah</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; color: rgb(111, 114, 113);">129 W Trade Street, Suite 1405 </div>
                <div style="text-align: justify; color: rgb(111, 114, 113);">Charlotte, NC 28202</div>
              </td>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; text-indent: -180pt; margin-left: 180pt; color: rgb(111, 114, 113);">279 West Main Street</div>
                <div style="text-align: justify; text-indent: -180pt; margin-left: 180pt; color: rgb(111, 114, 113);">Camden, TN 38320</div>
              </td>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; text-indent: -180pt; margin-left: 180pt; color: rgb(111, 114, 113);">1092 Confroy Drive </div>
                <div style="text-align: justify; text-indent: -180pt; margin-left: 180pt; color: rgb(111, 114, 113);">South Boston, VA 24592</div>
              </td>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; color: rgb(111, 114, 113);">1782 W 2300 S</div>
                <div style="text-align: justify; color: rgb(111, 114, 113);">West Valley City, UT 84119</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: left; font-weight: bold;">Amended Contract Details</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(23, 23, 23);">IperionX previously announced an award of up to US$47.1 million from the United States of America (U.S. Government) to strengthen the U.S. defense industrial base, which remains in place and
        with total contract value unchanged. </div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(23, 23, 23);">Under the amended contract between IperionX and the U.S. Government, the parties will fund a scale-up development program with a combined investment of up to US$95.2 million; US$47.1 million
        from the U.S. Government and US$48.1 million from IperionX.</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(23, 23, 23);">The amendment extends the performance period from 24 to 30 months from the date of the initial award to accommodate the expanded scope, which targets an increase in titanium production and
        manufacturing capacity at IperionX&#8217;s Titanium Manufacturing Campus to more than 1,000 metric tons per year. IperionX&#8217;s US$48.1 million cost share relates to incremental capital and operating costs required to execute the production expansion, which
        would be incurred irrespective of the timing or receipt of the U.S. Government funding.</div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(23, 23, 23);">The U.S. Government has previously obligated US$5 million to be applied to Titan Critical Minerals Project feasibility studies, and the remaining US$29.6 million awarded under the contract is
        expected to be obligated by the U.S. Government over the duration of the agreement, with the funds to be applied to increased titanium production capacity at IperionX&#8217;s Titanium Manufacturing Campus. The U.S. Government reserves the right to
        decline funding obligations on technical progress, agency needs, and availability of appropriations. Either party may terminate the contract at any time.</div>
      <div>&#160;</div>
      <div style="text-align: left; font-weight: bold;">About IperionX </div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(22, 22, 22);">IperionX is a leading American titanium metal and critical materials company &#8211; using patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap
        titanium, at lower energy, cost and carbon emissions. </div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(22, 22, 22);">Our Titan critical minerals project is the largest JORC-compliant mineral resource of titanium, rare earth and zircon minerals sands in the United States. </div>
      <div>&#160;</div>
      <div style="text-align: justify; color: rgb(22, 22, 22);">IperionX&#8217;s titanium metal and critical minerals are essential for advanced U.S. industries including space, aerospace, defense, consumer electronics, hydrogen, automotive and additive
        manufacturing. </div>
      <div style="text-align: justify; color: #161616;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z562d163f0ea74c8f93ff6509bfc99412" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(217, 217, 217); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 98%; vertical-align: top; background-color: rgb(217, 217, 217); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; color: rgb(73, 73, 73); font-style: italic; font-weight: bold;">Forward Looking Statements</div>
              <div style="text-align: justify; color: #002554; font-size: 8pt; font-style: italic; font-weight: bold;"> <font style="font-size: 10pt;"><br>
                </font></div>
              <div>
                <div style="text-align: justify; color: rgb(111, 114, 113); font-style: italic;">Information included in this release constitutes forward-looking statements. Often, but not always, forward looking statements can generally be identified by
                  the use of forward-looking words such as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221;, &#8220;estimate&#8221;, &#8220;anticipate&#8221;, &#8220;continue&#8221;, and &#8220;guidance&#8221;, or other similar words and may include, without limitation, statements regarding plans, strategies
                  and objectives of management, anticipated production or construction commencement dates and expected costs or production outputs. </div>
                <div style="text-align: justify; color: rgb(111, 114, 113); font-style: italic;"> <br>
                </div>
                <div style="text-align: justify; color: rgb(111, 114, 113); font-style: italic;">Forward looking statements inherently involve known and unknown risks, uncertainties and other factors that may cause the Company&#8217;s actual results,
                  performance, and achievements to differ materially from any future results, performance, or achievements. Relevant factors may include, but are not limited to, changes in commodity prices, foreign exchange fluctuations and general
                  economic conditions, increased costs and demand for production inputs, the speculative nature of exploration and project development, including the risks of obtaining necessary licenses and permits and diminishing quantities or grades of
                  reserves, the Company&#8217;s ability to comply with the relevant contractual terms to access the technologies, commercially scale its closed-loop titanium production processes, or protect its intellectual property rights, political and social
                  risks, changes to the regulatory framework within which the Company operates or may in the future operate, environmental conditions including extreme weather conditions, recruitment and retention of personnel, industrial relations issues
                  and litigation.</div>
                <div style="text-align: justify; color: rgb(111, 114, 113); font-style: italic;"> <br>
                </div>
                <div style="text-align: justify; color: rgb(111, 114, 113); font-style: italic;">Forward looking statements are based on the Company and its management&#8217;s good faith assumptions relating to the financial, market, regulatory and other
                  relevant environments that will exist and affect the Company&#8217;s business and operations in the future. The Company does not give any assurance that the assumptions on which forward looking statements are based will prove to be correct, or
                  that the Company&#8217;s business or operations will not be affected in any material manner by these or other factors not foreseen or foreseeable by the Company or management or beyond the Company&#8217;s control.</div>
                <div>&#160;</div>
              </div>
              <div style="color: rgb(111, 114, 113); font-style: italic; font-weight: normal; text-align: justify;">Although the Company attempts and has attempted to identify factors that would cause actual actions, events or results to differ materially
                from those disclosed in forward looking statements, there may be other factors that could cause actual results, performance, achievements, or events not to be as anticipated, estimated or intended, and many events are beyond the reasonable
                control of the Company. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Forward looking statements in these materials speak only at the date of issue. Subject to any continuing obligations under
                applicable law or any relevant stock exchange listing rules, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward-looking statements or to advise of any change in
                events, conditions or circumstances on which any such statement is based.</div>
              <div style="text-align: justify; color: #002554; font-size: 8pt; font-style: italic; font-weight: bold;"> <font style="font-size: 10pt;"><br>
                </font></div>
              <div style="text-align: justify; color: rgb(73, 73, 73); font-style: italic; font-weight: bold;">Competent Persons Statement </div>
              <div style="text-align: justify; color: #002554; font-size: 8pt; font-style: italic; font-weight: bold;"> <font style="font-size: 10pt;"><br>
                </font></div>
              <div style="color: rgb(111, 114, 113); font-style: italic; font-weight: normal; text-align: justify;">The information in this announcement that relates to Exploration Results and Mineral Resources is extracted from IperionX&#8217;s ASX Announcement
                dated October 6, 2021 (&#8220;Original ASX Announcement&#8221;) which is available to view at IperionX&#8217;s website at www.iperionx.com. The Company confirms that a) it is not aware of any new information or data that materially affects the information
                included in the Original ASX Announcement; b) all material assumptions and technical parameters underpinning the Mineral Resource Estimate included in the Original ASX Announcement continue to apply and have not materially changed; and c)
                the form and context in which the relevant Competent Persons&#8217; findings are presented in this report have not been materially changed from the Original ASX Announcement.</div>
              <div style="text-align: justify; color: #002554; font-size: 8pt; font-style: italic; font-weight: bold;"> <font style="font-size: 10pt;"><br>
                </font></div>
            </td>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(217, 217, 217); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>&#160;</div>
      <div style="text-align: right;"><font class="BRPFPageNumber" style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">3</font> </div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  = *D# 2(  A$! Q$!_\0
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MR)IT<,C^0I P/D; ]>0#S^-;1HN5M=S.52U]-CWRBOE;^T8/^B[WW_@)<?\
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GEDK=.IT>WE>[(;.2:2 &YA\F7H5W _CQ4U%%=D(N,4F[F+=W<__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
